Genix Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.44 Cr
as on 21-12-2024
- Revenue 0.27%
(FY 2023)
- Profit -32.91%
(FY 2023)
- Ebitda -68.94%
(FY 2023)
- Net Worth 12.21%
(FY 2023)
- Total Assets 16.10%
(FY 2023)
About Genix Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.44 Cr.
Rekha Saini and Rajesh Kumar serve as directors at the Company.
- CIN/LLPIN
U51909DL2012PTC245635
- Company No.
245635
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Dec 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Genix Lifescience Private Limited offer?
Genix Lifescience Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Fertilizers and Soil Additives, Fertilizer, Cardiovascular Drugs & Medication, Kidney Drugs, Immunosuppressive Drugs, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Genix Lifescience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rekha Saini  | Director | 23-May-2022 | Current |
| Rajesh Kumar | Director | 10-Jan-2014 | Current |
Financial Performance of Genix Lifescience.
Genix Lifescience Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.27% increase. The company also saw a substantial fall in profitability, with a 32.91% decrease in profit. The company's net worth Soared by an impressive increase of 12.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genix Lifescience?
Unlock access to Genix Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Mar 2024 | ₹1.01 M | Open |
Hdfc Bank Limited Creation Date: 21 Nov 2023 | ₹0.81 M | Open |
Hdfc Bank Limited Creation Date: 16 Oct 2023 | ₹4.00 M | Open |
How Many Employees Work at Genix Lifescience?
Genix Lifescience has a workforce of 0 employees as of May 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genix Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genix Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
